Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2684

Actual shortage: 240 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2435 (91%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

27 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-ABACAVIR/LAMIVUDINE 300MG 600MG TABLET Resolved 2022-08-18 2022-12-22 167237
PEDIATRIX 160MG SOLUTION Resolved 2022-08-18 2023-06-27 167194
NOVO-GESIC 325MG TABLET Resolved 2022-08-18 2022-09-23 167229
TEVA-LEVETIRACETAM 250MG TABLET Resolved 2018-09-27 2018-10-12 62458
TEVA-FLUVOXAMINE 50MG TABLET Resolved 2018-02-21 2019-05-28 40417
TEVA-FLUVOXAMINE 100MG TABLET Resolved 2018-02-21 2019-05-28 40420
TEVA-AMPHETAMINE XR 3.75MG 3.75MG 3.75MG 3.75MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-06 2019-01-31 60068
TEVA-AMPHETAMINE XR 5MG 5MG 5MG 5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-06 2019-01-31 60075
TEVA-AMPHETAMINE XR 6.25MG 6.25MG 6.25MG 6.25MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61330
TEVA-AMPHETAMINE XR 7.5MG 7.5MG 7.5MG 7.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61333
TEVA-AMPHETAMINE XR 1.25MG 1.25MG 1.25MG 1.25MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61336
TEVA-AMPHETAMINE XR 2.5MG 2.5MG 2.5MG 2.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-11-30 2019-01-31 68265
ACT BORTEZOMIB 3.5MG POWDER FOR SOLUTION Resolved 2020-01-30 2020-05-29 104930
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-17 68569
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-10 68572
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2020-02-13 68577
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-11-22 68580
ACT CABERGOLINE 0.5MG TABLET Actual shortage 2017-05-03 2017-10-05 8767
ACT CELECOXIB 200MG CAPSULE Resolved 2018-12-04 2019-04-11 68583
ACT CELECOXIB 200MG CAPSULE Resolved 2018-12-04 2019-08-06 68586

Showing 1 to 20 of 2684

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63937
EPIRUBICIN FOR INJECTION 2MG SOLUTION Discontinued 2020-10-22 2020-10-24 126906
EPTIFIBATIDE INJECTION 0.75MG SOLUTION Discontinued 2017-06-27 2017-06-27 14024
EPTIFIBATIDE INJECTION 2MG SOLUTION Discontinued 2017-06-27 2017-06-27 14027
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
GEMCITABINE FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14033
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
LEUCOVORIN CALCIUM INJECTION 10MG SOLUTION Discontinued 2017-06-27 2017-06-27 14036
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION 40MG POWDER FOR SOLUTION Discontinued 2021-09-23 2021-09-23 146061
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-04-11 2019-04-11 81321
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63955

Showing 61 to 80 of 250